1h Free Analyst Time
The non-invasive glucose monitoring devices market is forecasted to grow by USD 25.98 million during 2023-2028, accelerating at a CAGR of 15.46% during the forecast period. The report on the non-invasive glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diabetes and initiatives by governments, frequent launch of non-invasive glucose monitoring devices, and increasing demand for non-invasive procedures.
The non-invasive glucose monitoring devices market is segmented as below:
By Product
- Wearable
- Non-wearable
By End-user
- Home care settings
- Hospitals
- Clinics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the non-invasive glucose monitoring devices market covers the following areas:
- Non-invasive glucose monitoring devices market sizing
- Non-invasive glucose monitoring devices market forecast
- Non-invasive glucose monitoring devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global non-invasive glucose monitoring devices market: Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, Eser Co., Gluco Rx Ltd., Glucowise, F. Hoffmann La Roche Ltd., Informed Data Systems Inc. and One Drop., Medtronic Plc, Meta Materials Inc., Nemaura Medical Inc., Platinum Equity Advisors LLC, Rite Aid Corp., Taiwan Biophotonic Co., Tandem Diabetes Care Inc., and Walgreens Boots Alliance Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing focus on collaborations for business expansion.'
According to the report, one of the major drivers for this market is the increasing prevalence of diabetes and initiatives by governments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Ascensia Diabetes Care Holdings AG
- BlueSemi
- BoydSense SAS
- Cnoga
- Dexcom Inc.
- DiaMonTech AG
- Eser Co.
- Gluco Rx Ltd.
- Glucowise
- F. Hoffmann La Roche Ltd.
- Informed Data Systems Inc. and One Drop.
- Medtronic Plc
- Meta Materials Inc.
- Nemaura Medical Inc.
- Platinum Equity Advisors LLC
- Rite Aid Corp.
- Taiwan Biophotonic Co.
- Tandem Diabetes Care Inc.
- Walgreens Boots Alliance Inc.
